Janzen NK - Search Results

1

TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion.

Han KR, Bui MH, Pantuck AJ, Freitas DG, Leibovich BC, Dorey FJ, Zisman A, Janzen NK, Mukouyama H, Figlin RA, Belldegrun AS. Han KR, et al. Among authors: janzen nk. J Urol. 2003 Mar;169(3):899-903; discussion 903-4. doi: 10.1097/01.ju.0000051480.62175.35. J Urol. 2003. PMID: 12576809

2

Minimally invasive ablative approaches in the treatment of renal cell carcinoma.

Janzen N, Zisman A, Pantuck AJ, Perry K, Schulam P, Belldegrun AS. Janzen N, et al. Curr Urol Rep. 2002 Feb;3(1):13-20. doi: 10.1007/s11934-002-0005-8. Curr Urol Rep. 2002. PMID: 12084214 Review.

3

Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.

Han KR, Bleumer I, Pantuck AJ, Kim HL, Dorey FJ, Janzen NK, Zisman A, Dinney CP, Wood CG, Swanson DA, Said JW, Figlin RA, Mulders PF, Belldegrun AS. Han KR, et al. Among authors: janzen nk. J Urol. 2003 Dec;170(6 Pt 1):2221-4. doi: 10.1097/01.ju.0000096049.64863.a1. J Urol. 2003. PMID: 14634383

4

Emerging technologies in uroradiologic imaging.

Janzen NK, Laifer-Narin S, Han KR, Seltzer M, Thomas MA, Pantuck AJ, Belldegrun AS. Janzen NK, et al. Urol Oncol. 2003 Sep-Oct;21(5):317-26. doi: 10.1016/s1078-1439(03)00061-9. Urol Oncol. 2003. PMID: 14670537 Review.

5

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Janzen NK, et al. Urol Clin North Am. 2003 Nov;30(4):843-52. doi: 10.1016/s0094-0143(03)00056-9. Urol Clin North Am. 2003. PMID: 14680319 Review.

6

Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9.

Mukouyama H, Janzen NK, Hernandez JM, Lam JS, Caliliw R, Wang AY, Figlin RA, Belldegrun AS, Zeng G. Mukouyama H, et al. Among authors: janzen nk. Clin Cancer Res. 2004 Feb 15;10(4):1421-9. doi: 10.1158/1078-0432.ccr-03-0067. Clin Cancer Res. 2004. PMID: 14977845

7

Using protein expressions to predict survival in clear cell renal carcinoma.

Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Figlin RA, Horvath S, Belldegrun AS. Kim HL, et al. Clin Cancer Res. 2004 Aug 15;10(16):5464-71. doi: 10.1158/1078-0432.CCR-04-0488. Clin Cancer Res. 2004. PMID: 15328185

8

Cystic renal cell carcinoma: biology and clinical behavior.

Han KR, Janzen NK, McWhorter VC, Kim HL, Pantuck AJ, Zisman A, Figlin RA, Dorey FJ, Said JW, Belldegrun AS. Han KR, et al. Among authors: janzen nk. Urol Oncol. 2004 Sep-Oct;22(5):410-4. doi: 10.1016/S1078-1439(03)00173-X. Urol Oncol. 2004. PMID: 15464922

9

The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model.

Janzen NK, Perry KT, Han KR, Kristo B, Raman S, Said JW, Belldegrun AS, Schulam PG. Janzen NK, et al. J Urol. 2005 Apr;173(4):1368-74. doi: 10.1097/01.ju.0000147014.69777.06. J Urol. 2005. PMID: 15758807

10

Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.

Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S, Figlin RA. Kim HL, et al. J Urol. 2005 May;173(5):1496-501. doi: 10.1097/01.ju.0000154351.37249.f0. J Urol. 2005. PMID: 15821467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters